Both 3,4-dihydroxyphenylalanine and dopamine releases are regulated by Ca2+-induced Ca2+ releasing system in rat striatum

Neuroscience Letters

Volumn 362, Issue 3, 2004, Pages 244-248

  Zhu, Gang ^a   Okada, Motohiro ^a   Yoshida, Shukuko ^a,b   Hirose, Shinichi ^c   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Institute of Neuroscience and Molecular Biology   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

3,4 Dihydroxyphenylalanine; Ca2+ induced Ca2+ releasing system; Dopamine; Exocytosis; Microdialysis; Striatum

Indexed keywords

ADENOPHOSTIN A; CALCIUM CHANNEL L TYPE; CALCIUM ION; DOPA; DOPAMINE; INOSITOL TRISPHOSPHATE RECEPTOR; INOSITOL TRISPHOSPHATE RECEPTOR AGONIST; POTASSIUM ION; RECEPTOR; RYANODINE; RYANODINE RECEPTOR; RYANODINE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

AGONIST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CALCIUM TRANSPORT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; EVOKED RESPONSE; EXOCYTOSIS; MALE; MICRODIALYSIS; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REDUCTION; REGULATORY MECHANISM; REVIEW;

EID: 2442484389     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.03.031     Document Type: Article

References (20)

1. Berridge M.J. Neuronal calcium signaling. Neuron. 21:1998;13-26
2. Cordoba-Rodriguez R., Moore K.A., Kao J.P., Weinreich D. Calcium regulation of a slow post-spike hyperpolarization in vagal afferent neurons. Proc. Natl. Acad. Sci. USA. 96:1999;7650-7657
3. 2+-dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices. Brain Res. 617:1993;167-170
4. +-evoked serotonin release. Br. J. Pharmacol. 133:2001;557-567
5. Kusumi I., Koyama T. Algorithms for the treatment of acute side effects induced by neuroleptics. Psychiatry Clin. Neurosci. 53:(Suppl.):1999;S19-S22
6. Misu Y., Goshima Y., Miyamae T. Is DOPA a neurotransmitter? Trends Pharmacol. Sci. 23:2002;262-268
7. Misu Y., Kitahama K., Goshima Y. L-3, 4-Dihydroxyphenylalanine as a neurotransmitter candidate in the central nervous system. Pharmacol. Ther. 97:2003;117-137
8. Mori F., Fukaya M., Abe H., Wakabayashi K., Watanabe M. Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. Neurosci. Lett. 285:2000;57-60
9. Murakami T., Okada M., Kawata Y., Zhu G., Kamata A., Kaneko S. Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis. Br. J. Pharmacol. 134:2001;507-520
10. Nakanishi S., Maeda N., Mikoshiba K. Immunohistochemical localization of an inositol 1, 4, 5-trisphosphate receptor, P400, in neural tissue: studies in developing and adult mouse brain. J. Neurosci. 11:1991;2075-2086
11. 2+ channels to ryanodine receptors at presynaptic terminals. Amplification of exocytosis and plasticity. J. Gen. Physiol. 115:2000;519-532
12. Okada M., Nutt D.J., Murakami T., Zhu G., Kamata A., Kawata Y., Kaneko S. Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release. J. Neurosci. 21:2001;628-640
13. 2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis. Br. J. Pharmacol. 123:1998;805-814
14. Otani K., Mihara K., Okada M., Kaneko S., Fukushima Y. Crossover reaction between haloperidol and amoxapine for NMS. Br. J. Psychiatry. 159:1991;889
15. ++-triggered exocytosis. Science. 298:2002;781-785
16. Reuter H. Diversity and function of presynaptic calcium channels in the brain. Curr. Opin. Neurobiol. 6:1996;331-337
17. Sollner T., Bennett M.K., Whiteheart S.W., Scheller R.H., Rothman J.E. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell. 75:1993;409-418
18. Sudhof T.C. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature. 375:1995;645-653
19. 2+-dependent afterhyperpolarization current in rat CA3 pyramidal cells in vitro. J. Neurophysiol. 80:1998;2268-2273
20. 2+ signalling: problems and pitfalls. Trends Pharmacol. Sci. 19:1998;370-375